Cargando…

Irinotecan and Δ(9)-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers

There is growing interest regarding the use of herbal preparations based on Cannabis sativa for medicinal purposes, despite the poorly understood interactions of their main constituent Δ(9)-tetrahydrocannabinol (THC) with conventional drugs, especially cytostatics. The objective of this pilot study...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucić Vrdoljak, Ana, Fuchs, Nino, Mikolić, Anja, Žunec, Suzana, Brčić Karačonji, Irena, Jurič, Andreja, Prester, Ljerka, Micek, Vedran, Neuberg, Marijana, Čanović, Samir, Mršić, Gordan, Kopjar, Nevenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100385/
https://www.ncbi.nlm.nih.gov/pubmed/29865166
http://dx.doi.org/10.3390/molecules23061332
_version_ 1783348861267345408
author Lucić Vrdoljak, Ana
Fuchs, Nino
Mikolić, Anja
Žunec, Suzana
Brčić Karačonji, Irena
Jurič, Andreja
Prester, Ljerka
Micek, Vedran
Neuberg, Marijana
Čanović, Samir
Mršić, Gordan
Kopjar, Nevenka
author_facet Lucić Vrdoljak, Ana
Fuchs, Nino
Mikolić, Anja
Žunec, Suzana
Brčić Karačonji, Irena
Jurič, Andreja
Prester, Ljerka
Micek, Vedran
Neuberg, Marijana
Čanović, Samir
Mršić, Gordan
Kopjar, Nevenka
author_sort Lucić Vrdoljak, Ana
collection PubMed
description There is growing interest regarding the use of herbal preparations based on Cannabis sativa for medicinal purposes, despite the poorly understood interactions of their main constituent Δ(9)-tetrahydrocannabinol (THC) with conventional drugs, especially cytostatics. The objective of this pilot study was to prove whether the concomitant intake of THC impaired liver function in male Wistar rats treated with the anticancer drug irinotecan (IRI), and evaluate the toxic effects associated with this exposure. IRI was administered once intraperitoneally (at 100 mg/kg of the body weight (b.w.)), while THC was administered per os repeatedly for 1, 3, and 7 days (at 7 mg/kg b.w.). Functional liver impairments were studied using biochemical markers of liver function (aspartate aminotransferase—AST, alanine aminotransferase—ALP, alkaline phosphatase—AP, and bilirubin) in rats given a combined treatment, single IRI, single THC, and control groups. Using common oxidative stress biomarkers, along with measurement of primary DNA damage in hepatocytes, the degree of impairments caused at the cellular level was also evaluated. THC caused a time-dependent enhancement of acute toxicity in IRI-treated rats, which was confirmed by body and liver weight reduction. Although single THC affected ALP and AP levels more than single IRI, the levels of liver function markers measured after the administration of a combined treatment mostly did not significantly differ from control. Combined exposure led to increased oxidative stress responses in 3- and 7-day treatments, compared to single IRI. Single IRI caused the highest DNA damage at all timepoints. Continuous 7-day oral exposure to single THC caused an increased mean value of comet tail length compared to its shorter treatments. Concomitant intake of THC slightly affected the levels of IRI genotoxicity at all timepoints, but not in a consistent manner. Further studies are needed to prove our preliminary observations, clarify the underlying mechanisms behind IRI and THC interactions, and unambiguously confirm or reject the assumptions made herein.
format Online
Article
Text
id pubmed-6100385
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61003852018-11-13 Irinotecan and Δ(9)-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers Lucić Vrdoljak, Ana Fuchs, Nino Mikolić, Anja Žunec, Suzana Brčić Karačonji, Irena Jurič, Andreja Prester, Ljerka Micek, Vedran Neuberg, Marijana Čanović, Samir Mršić, Gordan Kopjar, Nevenka Molecules Article There is growing interest regarding the use of herbal preparations based on Cannabis sativa for medicinal purposes, despite the poorly understood interactions of their main constituent Δ(9)-tetrahydrocannabinol (THC) with conventional drugs, especially cytostatics. The objective of this pilot study was to prove whether the concomitant intake of THC impaired liver function in male Wistar rats treated with the anticancer drug irinotecan (IRI), and evaluate the toxic effects associated with this exposure. IRI was administered once intraperitoneally (at 100 mg/kg of the body weight (b.w.)), while THC was administered per os repeatedly for 1, 3, and 7 days (at 7 mg/kg b.w.). Functional liver impairments were studied using biochemical markers of liver function (aspartate aminotransferase—AST, alanine aminotransferase—ALP, alkaline phosphatase—AP, and bilirubin) in rats given a combined treatment, single IRI, single THC, and control groups. Using common oxidative stress biomarkers, along with measurement of primary DNA damage in hepatocytes, the degree of impairments caused at the cellular level was also evaluated. THC caused a time-dependent enhancement of acute toxicity in IRI-treated rats, which was confirmed by body and liver weight reduction. Although single THC affected ALP and AP levels more than single IRI, the levels of liver function markers measured after the administration of a combined treatment mostly did not significantly differ from control. Combined exposure led to increased oxidative stress responses in 3- and 7-day treatments, compared to single IRI. Single IRI caused the highest DNA damage at all timepoints. Continuous 7-day oral exposure to single THC caused an increased mean value of comet tail length compared to its shorter treatments. Concomitant intake of THC slightly affected the levels of IRI genotoxicity at all timepoints, but not in a consistent manner. Further studies are needed to prove our preliminary observations, clarify the underlying mechanisms behind IRI and THC interactions, and unambiguously confirm or reject the assumptions made herein. MDPI 2018-06-01 /pmc/articles/PMC6100385/ /pubmed/29865166 http://dx.doi.org/10.3390/molecules23061332 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lucić Vrdoljak, Ana
Fuchs, Nino
Mikolić, Anja
Žunec, Suzana
Brčić Karačonji, Irena
Jurič, Andreja
Prester, Ljerka
Micek, Vedran
Neuberg, Marijana
Čanović, Samir
Mršić, Gordan
Kopjar, Nevenka
Irinotecan and Δ(9)-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers
title Irinotecan and Δ(9)-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers
title_full Irinotecan and Δ(9)-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers
title_fullStr Irinotecan and Δ(9)-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers
title_full_unstemmed Irinotecan and Δ(9)-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers
title_short Irinotecan and Δ(9)-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers
title_sort irinotecan and δ(9)-tetrahydrocannabinol interactions in rat liver: a preliminary evaluation using biochemical and genotoxicity markers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100385/
https://www.ncbi.nlm.nih.gov/pubmed/29865166
http://dx.doi.org/10.3390/molecules23061332
work_keys_str_mv AT lucicvrdoljakana irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT fuchsnino irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT mikolicanja irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT zunecsuzana irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT brcickaraconjiirena irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT juricandreja irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT presterljerka irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT micekvedran irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT neubergmarijana irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT canovicsamir irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT mrsicgordan irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers
AT kopjarnevenka irinotecanandd9tetrahydrocannabinolinteractionsinratliverapreliminaryevaluationusingbiochemicalandgenotoxicitymarkers